Clinical Trial Update: Body Composition Monitor in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluation of a body composition monitor in patients with end-stage renal disease undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: End Stage Renal Disease | Phase 4 | Status: UNKNOWN